Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

First clinical trial of human gene therapy for hemophilia begins

Dec. 3, 1998

U.S. patent covers transgenically produced rhATIII

Dec. 3, 1998

Microbix and Gensia Sicor terminate licensing agreement

Dec. 2, 1998

Preclinical studies of XV-454 support further testing of novel fibrinogen antagonist

Dec. 1, 1998

Searle revises OPUS-TIMI 16 trial evaluating orbofiban acetate

Nov. 25, 1998

Two new antiplatelet agents marketed in Germany

Nov. 23, 1998

Synthelabo discloses orally active human thrombin inhibitors

Nov. 18, 1998

PARAGON A establishes effective dose of lamifiban in unstable angina

Nov. 17, 1998

New thrombin inhibitors from Merck & Co. for thromboembolic disorders

Nov. 16, 1998

Anti-FIX/IXa antibody prevents thrombus formation in rat model

Nov. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...